Session 8: Marketing and Strategy (Practitioner) Athena Prib, RTTP Commercial Director, gemaker Chair of Marketing Committee, ATTP
|
|
- Daniel Burns
- 6 years ago
- Views:
Transcription
1 Session 8: Marketing and Strategy (Practitioner) Athena Prib, RTTP Commercial Director, gemaker Chair of Marketing Committee, ATTP
2 Session 8: Marketing and Strategy (Practitioner) Marketing versus selling Creating an opportunity pipeline Creating strategic themes in marketing to attract licensees Estimating customer value for your technology
3 What s involved? NEW PRODUCT, SERVICE, BUSINESS & MARKETS Scope requirements of the project to grow business ASSESS & PIVOT Customer feedback interviews Competitor monitoring IP landscape monitoring SALES/START-UP Secure funding Business development Business set-up Recruitment MARKETING Prepare and implement marketing strategy and plan Prepare promotional material (web, print, video, social media) Prepare award applications MARKET RESEARCH Desktop searches Customer Interviews Competitor analysis Identify funding opportunities Identify partnering opportunities Markets and market sizes Due diligence Pricing and placement IP landscape COMMERCIAL CASE Financial modelling Commercial strategy & plan Intellectual property strategy Resource planning Funding strategy PROOF OF CONCEPT (POC) Find partners for development Prepare and negotiate terms of agreements for partners Apply for grant funding for POC Project manage POC
4 What we are focusing on today MARKET RESEARCH Desktop searches Customer Interviews Competitor analysis Identify funding opportunities Identify partnering opportunities Markets and market sizes COMMERCIAL CASE Financial modelling Commercial strategy & plan Intellectual property strategy Resource planning Funding strategy SALES Secure funding or sales Business development MARKETING Prepare and implement marketing strategy and plan Prepare promotional material (web, print, video, social media) Prepare award applications
5 Marketing versus selling Marketing always changes but selling stays the same. Marketing Selling
6 Marketing versus selling Same aim: increase revenue Marketing Broader than sales Customer focussed How to reach? 1 way conversation now a 2 way (thanks to social media) Whole process of satisfying a customer Strategy to engage customers build relationships Promote price & product Fulfill customer needs 당겨 푸시 Selling Match customer to product Product focused Product is ready to sell Approach is to satisfy the customers end needs 2 way conversation Customers does the talking Meet target revenue A result of marketing
7 Marketing Functionalit y Brand Packaging Services Product Promotion Pricing Placement
8 Marketing Functionalit y Brand Packaging Services Product Promotion Advertising Website Social Media Brochures Events What s the value? Cost Terms Discount Pricing Placement Distribution Logistics How to get it out
9 What do you do in sales? Customers Contracts Find new customers Customer relationship management Solution based selling? Attend events, meeting, functions Set terms Negotiate contracts Manage the relationship
10 Typical Investors Cash Flow or Revenue Generally operating in this area Technology Creation & Development Market Introduction - Business & Product Development Growth The Chasm Valley of Death Research Inventors Angels VCs Stock Owners Public Sector Private Sector
11 Cost of developing prescription drug 10 year + Study $1.4 billion average out-of-pocket cost $312 million is spent on post approval development test new indications, formulations, and dosage strengths $1.2 billion in returns that investors forgoes $2.9 billion for a life-cycle cost SOURCE: Tufts Center for the Study of Drug Development Pricing should be based not on R&D costs but on the value a drug delivers to patient
12 Customer hurdles How will it help me? How will it help my business? Can I trust you? Are you the best in the world? Does it work? What does it cost? Is my space protected?
13 High priority Proven Phase 2 Aligning the stars A new drug takes investment of time & $$ ~15 years ~ US$1.4 Billion Resources team Commitment Financial Viability Patent Position
14 Gardasil Cervical cancer (HPV) vaccine the second biggest killer of women worldwide. Used 121 countries world wide Saves 250,000 lives every year Discovered at UQ 1991 Prov filed by Uniquest 1994 Patent granted Patent dispute started CSL partnered and licensed 1996 CSL sub-licensed to Merk & Co Federal Drug Administration (FDA) in the US approved 2007 Patent dispute settled Phase 3 clinical trial involved over 12,000 women aged from thirteen countries, with half receiving Gardasil and the other half receiving a placebo.
15 The killer experiment The evidence that will make or break your case. Leave no doubt that it works Convincing data Animals, samples or people Tight controls It is not fishing, ie it is not seeing to see if works it proving it
16 Positioned in Category Interest Established Sales cycle Gap Acknowledged Need Agreed Offer Understood Depending on the technology might take years or months Preference Formed Decision Made Revenue
17 Australian challenges No middle tier companies (ie no phase 1 or 2) Location Go to the US Success in Australia is not measured by seeing a product on the market Licensing the tech If they do the deal is irrelevant
18 Overview Headquartered in Sydney, Australia in-house research labs, Bay Area of San Francisco, CA, USA Work collaboratively with a number of laboratories in Australia, the USA & China. Collaborations with NewSouth Innovations / UNSW since 2007 invested in a number of CRAs Patent protection is focused on value add: Research programs technology improvements and Composition of matter patents for products in development for a variety of therapeutic indications Commercialisation opportunities In-house programs target chronic and lifethreatening conditions which are geneassociated, and for which there is no effective treatment or cure UNSW Developing a treatment for nonsmall cell lung cancer (NSCLC) which is resistant to chemotherapy - Tribetarna Lung cancer is the highest-ranked cancer in terms of incidence and mortality NSCLC accounts for more than 80% Children's' Cancer Institute of Australia at UNSW produced in vitro data showing safety and efficacy. Proof of principle established Getting ready for clinical trials A Phase I/IIa clinical trial
19 Estimating customer value for your technology What is the cost to the customer if they don t buy? X Not how much it cost you to create and prove the technology. Money? $ Time? What does cost to do now? How much will you save your customer? Cost of transferring technology What does it replace? What will cost to replace? More efficient? More product in shorter time? Development time shorter? Resources? Waste? Equipment? Space? People? Patents?
20 Many ways to slice the pie What will work for your prospective customer?
21 Regions Where are they? What have you got? What does it solve? Competitors / Partners What are their priorities? What are the patterns? What is high value? - Brand? - Social good? - Dollars? What is easiest to access? - Sector? - Region? - People? Sectors Who does it solve it for?
22 People World Class Researchers and research teams, publishing in top journals Infrastructure World class facilities, laboratories Broad Areas E.g.: Therapy, Diagnostic, Devices Indications E.g.: Cardiovascular, CNS Disease E.g.: Cancer
23 Relationship selling you want to work with us because we are easy to work with Easy Access IP Categories simple: Software, Photovoltaic, Easy Access IP
24
25
26 Sell the relationship first Then group to themes
27
28
29
30 Making an opportunity pipeline New customers? Who you know. Not what you know. Start looking easy steps Networks Researchers Business / Industry groups Alumni Web Social Media: Linkedin, facebook, twitter Get them to find you harder steps Form network groups An offer they can t refuse Stand out from the crowd : What s your point of difference? Client HOT WARM COOL Prospects
31 @ATTPmedia LinkedIn group Facebook news Engage in the community Share your knowledge
32 Athena Prib, RTTP Commercial Director P:
33 Extra slides for consideration
34 Tool to help focus your sales Product What are you selling Target Market What types of companies? What are they interested in? What is their size What are their characteristics? Strategy How are you going to get there? Buying Where are you generating an income? Working Have terms, in negotiations, have quotes Marketing Sending information, in dialogue Reference What have you sold in the past?
35 Marketing Example: Alkane
36 Marketing Example: CRC for Low Carbon Living
37 Modified shark antibodies Funded by URE (mining company) First of its kind, investment from miner Funded around ~ 2 million a year Barriers with board, move to quickly not so patient 7 years operating spinout from Latrobe University through Cooperative Research Centre for Diagnostics Established 2007 January 2012 signed an agreement with international pharmaceutical company, Roche, to evaluate and identify shark antibody binders Working on animal models 1 BD = CEO Staff mainly research to validate the technology Outsource testing / cheaper o/s
Policies that encourage innovation in middle-income countries
December 2012 Policies that encourage innovation in middle-income countries The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) asked Charles River Associates (CRA) to
More informationINTERIM RESULTS AS OF MARCH 31, 2017
INTERIM RESULTS AS OF MARCH 31, 2017 1 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of
More informationA Cure for the Common Cold-Call
Social Media Companies that market primarily on a business-to-business (B2B) basis have been slow to move beyond the traditional outbound marketing tactics to a more inbound, social marketing strategy.
More informationOffice for Human Subject Protection. University of Rochester
POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,
More informationPITCHING TO INVESTORS OR PARTNERS PITCH THEN PLAN
PITCHING TO INVESTORS OR PARTNERS PITCH THEN PLAN Arthur A. Boni, Ph. D. John R. Thorne Distinguished Career Professor of Entrepreneurship Tepper School of Business Carnegie Mellon University 2017, Arthur
More informationHK BIP Forum, December 4-5, 2014
HK BIP Forum, December 4-5, 2014 Building Success in Technology Transfer Dr Andy Sierakowski, Former Chair, KCA and Joint Chair International Committee ITTN Beijing Australia China Trade Shows Strong Growth
More informationWITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT
WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT Pharmaceutical IP Policy Issues Economics - Business Model IP TPP Global Challenges
More informationJanuary (San Francisco, CA) January 8, 2018
January 2017 J.P. Morgan 36 th Annual Management Healthcare Presentation Conference (San Francisco, CA) January 8, 2018 DISCLAIMER Certain information contained in this presentation relates to or is based
More informationAntisense Therapeutics Ltd ASX:ANP January 2017
Antisense Therapeutics Ltd ASX:ANP January 2017 Forward Looking Statements This presentation contains forward-looking statements regarding the Company s business and the therapeutic and commercial potential
More informationDavid R Clark Director of Investment Services
David R Clark Director of Investment Services 1 What is SATAI? The San Antonio Technology Accelerator Initiative Mission The SATAI Network exists to Inspire technology innovation and commercialization,
More informationNational Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy
From Hope to Cures: The Value of Biopharmaceutical Innovation National Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy HIV/AIDS: Then
More informationMcCombs Knowledge To Go November 9, 2010
McCombs Knowledge To Go November 9, 2010 Rob Adams 2010 Market Validation - Slide 1 If You Build It Will They Come? Three Steps to Test and Validate Any Market Opportunity UT Alumni Network Knowledge to
More informationFIGHT FOOD WASTE & FRAUD CRC. To protect and profit Australia s food & wine industry
FIGHT FOOD WASTE & FRAUD CRC To protect and profit Australia s food & wine industry WHY YOU SHOULD INVEST IN THIS CRC? You are an organisation in the food or beverage industry concerned about the 42% of
More informationRoche, Roche Molecular Diagnostics and more
, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional
More informationPartnering with the NIH: Technology Transfer. Why partner?
Partnering with the NIH: Technology Transfer Jennifer Wong, M.S. Technology Development Coordinator National Institute of Mental Health Why partner? Enhance company s portfolio De-risks developing a technology
More informationPrescription Medicines: Costs in Context
Prescription Medicines: Costs in Context 2017 We are in a new era of medicine where breakthrough science is transforming care with innovative treatment approaches... Then Now Medicines made of chemical
More informationAbout Clinical Trials
About Clinical Trials A guide for people with CF and their families INSIDE Who Can Participate in a Clinical Trial? Clinical Research Basics Who Is Involved in Clinical Research? Informed Consent Your
More informationInnovative Approaches to Saving Patients Money on Prescription Drug Costs
Innovative Approaches to Saving Patients Money on Prescription Drug Costs April 2018 1 Innovative Approaches to Saving Patients Money on Prescription Drug Costs Executive Summary As prescription drug prices
More informationPharmamarketing - strategic challenges
Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions
More informationSocial Campus Report. A global survey of higher education social media usage
2017 Social Campus Report A global survey of higher education social media usage 2017 Social Campus Report A global survey of higher education social media usage Social media has transformed the communication
More informationReasons Why Employee Referrals Matter to Small to Mid-sized Businesses
Reasons Why Employee Referrals Matter to Small to Mid-sized Businesses CLICK BELOW TO LEARN MORE ON WHY REFERRALS MATTER: INTRODUCTION One of the toughest challenges small to mid-sized businesses (SMBs)
More informationESTIMATE THE IMPACT OF TIME SAVINGS ON YOUR DRUG DEVELOPMENT PROGRAM, ASSET VALUE AND FINANCIAL COMPANY PERFORMANCE
ESTIMATE THE IMPACT OF TIME SAVINGS ON YOUR DRUG DEVELOPMENT PROGRAM, ASSET VALUE AND FINANCIAL COMPANY PERFORMANCE An Economic Comparison of Programmatic and Transactional Development Models PETER SAUSEN,
More informationTHE ROLES AND RESPONSIBILITIES CHART By Kirk J. Hulett
THE ROLES AND RESPONSIBILITIES CHART By Kirk J. Hulett The structure of most entrepreneurs businesses happens organically. Issues like who performs what task and who makes this decision versus that decisions
More informationUsing Your Prescription. Drug Program. Answers to important questions about retail pharmacy and mail order purchasing
Using Your Prescription Drug Program Answers to important questions about retail pharmacy and mail order purchasing Welcome! We know you re going to enjoy the many advantages of your prescription drug
More informationMarketing Your Business to Investors
Marketing Your Business to Investors Can You Manage Money? Steven Rogers, Redstones LLC srogers@redstones.com www.redstones.com 1 Always Remember This is my perspective of finding money based on my experience
More informationABPI response to European Commission consultation on advanced therapy medicinal products
ABPI response to European Commission consultation on advanced therapy medicinal products 28 March 2013 ABPI response to European Commission consultation on the regulation of advanced therapy medicinal
More informationThe Economics of New Drug Development: Costs, Risks, and Returns
The Economics of New Drug Development: Costs, Risks, and Returns Joseph A. DiMasi, Ph.D. Tufts Center for the Study of Drug Development Tufts University The New England Drug Metabolism Group Spring Meeting
More informationBrand Ambassador FAQs
Brand Ambassador FAQs 2018-2019 Summary 1. Before you apply 2. During your application 3. Application Process 4. Once you ve been hired 5. Campaign structure Before you apply. What is the difference between
More informationRoche Committed to Innovation. Sal. Oppenheim European Healthcare Investors Conference Frankfurt, September 2, 2008
Roche Committed to Innovation Sal. Oppenheim European Healthcare Investors Conference Frankfurt, September 2, 2008 This presentation contains certain forward-looking statements. These forward-looking statements
More informationSirtex Medical Limited
Sirtex Medical Limited Market Update 2011 Half Year Results Gilman Wong CEO Darren Smith CFO 9-10 March 2011 SIR-Spheres is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Understanding the Sirtex
More informationValuing and Licensing Intellectual Property. Richard Williams
c Healthcare Valuing and Licensing Intellectual Property Richard Williams 9 May 2001 Agenda Exploitation of intellectual property The licence route- why and when? Choosing a partner Practical considerations
More informationThe Promise and Challenge of Adaptive Design in Oncology Trials
THE POWER OFx Experts. Experience. Execution. The Promise and Challenge of Adaptive Design in Oncology Trials Clinical oncology trials are more complex and time consuming than those in any other therapeutic
More information100M sufferers in US (2.2B worldwide) 65% of people ages NOCTURIA is the #1 urology complaint of men and women 55-84
INVESTOR DECK PAXEROL for NOCTURIA 100M people in the US suffer from a problem for which we have a strong solution. The patents are issued. We are raising funds for EU launch and FDA trial. David A. Dill,
More informationAdaptive Design for Medical Device Development
Adaptive Design for Medical Device Development A guide to accelerate clinical development and enhance portfolio value Executive Summary In May 2015, the FDA released a draft guidance document regarding
More informationGood morning and thank you for joining us for our quarterly update.
Q1 2018 Earnings Conference Call May 7, 2018 11:00 AM ET Introduction and Forward Looking Statements in APPENDIX I Garo Armen Good morning and thank you for joining us for our quarterly update. We have
More informationOpen the door and unlock opportunities with the Cisco Services Icebreaker Program. What s hidden in your Cisco Installed Base? TD Azlan, Services
What s hidden in your Cisco Installed Base? Open the door and unlock opportunities with the Cisco Services Icebreaker Program Your Personalised Business Case - prepared for TD Azlan, Services Your Personalised
More informationTable of Contents. Presented by
Table of Contents Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035 Fax: (408) 978-8925 www.hightechdecisions.com May 2017 TABLE OF CONTENTS
More informationAlmac Overview.
Almac Overview www.almacgroup.com 2 Welcome to Almac 3 Who is Almac? Almac is a world leading drug development & commercial services company; providing an expanding array of innovative solutions worldwide
More informationHistory has Demonstrated that Sub-optimal CDx Strategies can Impact Drug Success
DOES YOUR COMPANION DIAGNOSTIC STRATEGY BEST P OSITION YOU FOR SUCCESS? History has Demonstrated that Sub-optimal CDx Strategies can Impact Drug Success Real-World Examples 1 st Year Sales Increased complexity
More informationGlobal Paradigm Shift in Pharma is CRAMS still the right model for India?
Global Paradigm Shift in Pharma is CRAMS still the right model for India? My own reflections, influenced by Lonza's 30 year life as a contract manufacturer with many ups and downs and still weathering
More informationGLOSSARY OF TERMS ENTREPRENEURSHIP AND BUSINESS INNOVATION
Accounts Payable - short term debts incurred as the result of day-to-day operations. Accounts Receivable - monies due to your enterprise as the result of day-to-day operations. Accrual Based Accounting
More informationVolunteering for Clinical Trials
Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked
More informationWRITING A SUCCESSFUL SBIR / STTR COMMERCIALIZATION PLAN. Ed Kase Business Development Consultant
WRITING A SUCCESSFUL SBIR / STTR COMMERCIALIZATION PLAN Ed Kase Business Development Consultant About Ed Kase BS in mechanical engineering from Clarkson University MBA from Colorado State University 20+
More informationPharmaceutical Product Development NASDAQ: PPDI. Dan Darazsdi Chief Financial Officer. Credit Suisse Healthcare Conference November 2009
Pharmaceutical Product Development NASDAQ: PPDI Dan Darazsdi Chief Financial Officer Credit Suisse Healthcare Conference 2009 12 November 2009 Safe Harbor Except for historical information, all of the
More informationDRUG DEVELOPMENT TARGET PRODUCT PROFILE
DRUG DEVELOPMENT TARGET PRODUCT PROFILE Template This template provides suggested considerations that may assist biopharmaceutical companies in their decisions as to whether to proceed with a drug development
More informationRoche in Australia Innovation Leader
Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving
More informationStrategic trends facing the pharmaceutical industry and their implications for marketing skills development Received: 4th September, 2002
Strategic trends facing the pharmaceutical industry and their implications for marketing skills development Received: 4th September, 2002 Gill Butler has worked in the pharmaceutical industry for 21 years,
More information7 Ways to Increase the Profitability of Your Pediatric Dental Practice
7 Ways to Increase the Profitability of Your Pediatric Dental Practice 770-823-3534 www.thepdaa.com pdaadirector@gmail.com 1 Over the last decade, the average dentist has seen income stagnate or even decrease.
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More information2017 Clinical Trials Data Library
2017 Clinical Trials Data Library Copyright 2017 CenterWatch. Investigator Databank Total Active Principal Investigators Worldwide Active Investigators Worldwide Global Distribution of Investigative Sites
More informationQ Presentation , Oslo
Q4 2017 Presentation 01.02.2018, Oslo Agenda Highlights BetaGlucans Animal- and Consumer health Cancer Advanced wound care Enzymes Molecular and new markets Q4 Financials Outlook for 2018 2 Biotec in brief
More informationVoyager Therapeutics - A Spinout from UMass Gene Therapy and RNAi Technologies
University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2016 UMass Center for Clinical and Translational Science Research Retreat
More informationSocial media: time waster or powerful business tool?
Social media: time waster or powerful business tool? Mari Anne Snow CEO, SophiaThink Consulting 22 June, 2010 Agenda What is social media? Current landscape: May 2010 How these tools impact daily life
More informationTTS Global Initiative Business Development (BD)
TTS Global Initiative Business Development (BD) FFH 2.0 - Stuttgart, Germany, 15 October, 2014. Understanding the business development opportunity in Healthcare / Life Science. What do we mean and understand
More informationDIGITAL PLAN FOR SUCCESS
PUNCH DIGITAL DIGITAL MARKETING BLUEPRINT PLAN FOR SUCCESS About PUNCH digital At PUNCH digital we specialise in connecting businesses with their customers. Whether you re a small grassroots business or
More informationBrazil Gastric Balloon Procedures Outlook to 2020
Brazil Gastric Balloon Procedures Outlook to 2020 Reference Code: GDMECC0472PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationSAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014
Mexico Orthopedic Prosthetics Market Outlook to 2020 Reference Code: GDMECC0156DB Publication Date: February 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of
More informationThere must be a simpler method of genotyping people? 2001 Solution found. A A team is assembled. Biopysicist (Me) Physical Chemist Clinical Biochemist
Trials and tribulations, an academic in a commercial world. Dr Tim R. Dafforn School of Biosciences Birmingham Adventures in Commercialisation 2000 Cambridge it all begins with an question. There must
More informationCURRENT ISSUES IN INTELLECTUAL PROPERTY: A PATIENT PERSPECTIVE
CURRENT ISSUES IN INTELLECTUAL PROPERTY: A PATIENT PERSPECTIVE Consumer Advocare Network s submission to WHO's Second Public Hearing on Public Health Innovation and Intellectual Property The Consumer Advocare
More informationREIMAGINING DRUG DEVELOPMENT:
Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY
More informationomputing Software B2B Content Marketing 2010: Industry Report
omputing Software B2B Content Marketing 2010: Industry Report 1 FOREWORD In September 2010, Junta42 and MarketingProfs in conjunction with the Business Marketing Association (BMA) and American Business
More informationStrategy and Structure
Whole Foods Market Strategy and Structure Jawaher Alotaibi June 18, 2015 WFM s Environment Whole Foods Market (WFM) is a natural and organic supermarket that it s known for healthy and natural food products.
More informationAnnual General Meeting KPMG Level 36, 727 Collins St Melbourne Tuesday 21 November am
Annual General Meeting 2017 KPMG Level 36, 727 Collins St Melbourne Tuesday 21 November 2017 11.00am Forward looking statements Certain statements in this presentation relate to the future, including forward
More informationMessage from Genentech s Executive Sponsor
Message from Genentech s Executive Sponsor Dear Prospective Fellow: Genentech is excited to be a part of the University of the Pacific s Fellowship in Industry Program (FIP) for Doctor of Pharmacy graduates.
More informationFrom Ripe to Ready: Lead Nurturing is the Silver Bullet in B2B Marketing
From Ripe to Ready: Lead Nurturing is the Silver Bullet in B2B Marketing Presented by Tyler Garns Director of Marketing, Infusionsoft @tylergarns Typical Customer Lifecycle Generate Interest Sell, Sell,
More informationOwning Your Brand s Social Community Drives More Shoppers and Sales
Owning Your Brand s Community Drives More Shoppers and Sales Contents 1 Executive Summary 3 Introduction 5 Research Scope & Methodology 6 Why They Come 7 Comprehensive Findings 9 Retail 11 Communication
More informationMarketing Excellence
Marketing Excellence Contents 1 Introduction... 2 2 Developing The Product... 2 3 Positioning The Product... 3 4 Market Planning... 4 5 Pricing... 4 6 Discounting... 5 7 Value vs Price... 6 8 Media Relations...
More informationHow to Use. Search & Social to Increase Sales FAST
How to Use Search & Social to Increase Sales FAST Gloria Lafont President/Owner: ActionMarketingCo.com Editor: PromoBusinessSuccess.com Direct: 954-372-7967 Email Gloria@ActionMarketingCo.com LinkedIn
More informationBuilding a Career in the Pharmaceutical Industry: Personal Reflections. Carlo Nalin, PhD Executive Director Novartis Oncology
Building a Career in the Pharmaceutical Industry: Personal Reflections Carlo Nalin, PhD Executive Director Novartis Oncology 2 Career Development: Personal Reflections C Nalin 5 April 2016 Cornell BEST
More informationSession 11 PD, Life Insurance Distribution Trends Part 1. Moderator: Patrick T. Leary. Presenters: Patrick T. Leary Carol McManus
Session 11 PD, Life Insurance Distribution Trends Part 1 Moderator: Patrick T. Leary Presenters: Patrick T. Leary Carol McManus SOA Life & Annuity Symposium May 4, 2015 Life Insurance Distribution Trends
More informationM&A Focus: Biotechnology
WWW.IBISWORLD.COM Month 2012 1 Follow on head on Master page A May 2013 M&A Focus: Biotechnology By Anna Son Growing pains from the Patent Cliff will lead Big Pharma companies to invest in promising biotechnology,
More informationSPERRY VAN NESS VALUE PROPOSITION
SPERRY VAN NESS VALUE PROPOSITION All of the tools, materials, and systems you need to grow your business. Why Franchise with Sperry Van Ness? With our advanced commercial real estate technology and systems,
More informationADAPT. EVOLVE. THRIVE. HOW CAN LAW FIRMS RETAIN THEIR MARGINS AND GROW THEIR PRACTICES IN CHANGING TIMES?
ADAPT. EVOLVE. THRIVE. HOW CAN LAW FIRMS RETAIN THEIR MARGINS AND GROW THEIR PRACTICES IN CHANGING TIMES? TABLE OF CONTENTS Executive summary 3 Four big changes 3 Two big opportunities 6 Adapting to thrive
More informationFULL FUNNEL MARKETING STRATEGIES
FULL FUNNEL MARKETING STRATEGIES INTRODUCTION The funnel is a well-understood marketing concept that is usually split into three stages each of which presents marketers with a unique set of challenges.
More informationThe template. Slides. Try to use images where possible to convey your message.
The template Use this template to begin crafting the presentation and pitch around your venture. Feel free to augment, rearrange, etc... but this is the general outline most investors are expecting to
More information[Type Viktoria Kanevsky VKEcom.com OnlineBoutiquesMBA.com
It goes first but should you should write it last. It summarizes what your store/boutique is about, highlights of your growth if you are already in the business, your products, and your goals. Here what
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationInsurance Marketing Benchmarks Report
Insurance Marketing Benchmarks Report 2017 Introduction How can I attract and maintain policyholders? That s a question successful insurance agents ask themselves on a regular basis. Better coverage, competitive
More informationCORPORATE NEWS EARNINGS PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF 2016
CORPORATE NEWS EARNINGS PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF 2016 Positive remimazolam data in pivotal U.S. Phase III study for procedural sedation during colonoscopy
More informationCEO Presentation Annual General Meeting
ASX code: LBT lbtinnovations.com CEO Presentation Annual General Meeting Adelaide, Australia 21 October 2015 Lusia Guthrie, CEO Disclaimer This document contains certain forward-looking statements that
More informationoctave A simple overview digital Digital Marketing Guide
Digital Marketing Guide A simple overview A brief introduction Contents 1.0 Introduction 2.0 Changing Media 2.1 Internet Usage 2.2 User activity online 2.3 Social Media 2.4 Mobile 2.5 Ecommerce - Impact
More informationInbound Marketing: The Missing Link in ROI-Driven PR
Inbound Marketing: The Missing Link in ROI-Driven PR A PLAYBOOK FOR BRIDGING PR TO LEAD GENERATION AND SALES Since its founding 120 years ago, the PR industry has failed to meaningfully innovate. In fact,
More informationHarnessing the Power of Social Media MARKETING
Harnessing the Power of Social Media MARKETING Assessing and understanding social media resources. -Laurie Morse-Dell, Center for Technology & Business Understanding Social Media Resources 1. Know what
More informationMarketing Plan Outline - Date: Intellectual Property Of: Business Mission Statement: I. Executive Summary
Page 1 of 39 This template is for MCE123 Marketing customers only. Do not reproduce the document in any way other than client inquiries. It must remain intact on MCE123 s web servers. Marketing Plan Outline
More informationFOCUS REIMBURSEMENT STRATEGY TO DEMONSTRATE FULL VALUE STORY
WHITE PAPER FOCUS REIMBURSEMENT STRATEGY TO DEMONSTRATE FULL VALUE STORY By Nicole May, Research Analyst at Cutting Edge Information OVERVIEW National and private payers, especially in the US and EU, are
More informationAustralia: A Dynamic Environment for Conducting Clinical Trials
Australia: A Dynamic Environment for Conducting Clinical Trials MTPConnect s goal is to accelerate the growth of Australia s MTP sector Industry Associations Governments Universities Researchers Investors
More informationINVEST IN TOPADUR! HEALTH IS THE MOST IMPORTANT THING IN LIFE!
INVEST IN TOPADUR! HEALTH IS THE MOST IMPORTANT THING IN LIFE! TOPADUR PHARMA AG a promising Swiss start-up investment Global Medical Need: Diabetes mellitus is one of the major health concerns worldwide.
More informationYour Action Plan to Launch New Paid Content
Is your circulation flat? Are you having trouble attracting new subscribers? Do you want to expand your offerings to new markets? If yes, then consider launching a new paid subscription product. However,
More informationYOU ARE ABOUT TO DISCOVER THE TRUTH ABOUT STANDARD AD SHARE PLATFORMS AND WHY EVERY AD-SHARE ENTHUSIAST IS JOINING CAPS
YOU ARE ABOUT TO DISCOVER THE TRUTH ABOUT STANDARD AD SHARE PLATFORMS AND WHY EVERY AD-SHARE ENTHUSIAST IS JOINING CAPS WE STRONGLY ADVISE THAT YOU STUDY THIS DOCUMENT CAREFULLY, YOUR FINANCIAL FUTURE
More informationTEACHING TOLERANCE. The Economics of Social Media. By Joao Frenandes Silva
TEACHING TOLERANCE DIGITAL LITERACY TOLERANCE.ORG The Economics of Social Media By Joao Frenandes Silva Every day, billions of people post, share, comment, and chat on online social media platforms. More
More information1Word Initial Coin Offering (ICO) O C T O B E R 2017
1Word Initial Coin Offering (ICO) O C T O B E R 2017 Blockchain-powered ENGAGEMENT & REVENUE PLATFORM for publishers & brands 1World Value Proposition 1World Interactive Platform for publishers and brands
More informationSaaS Marketing Strategy Template
SaaS Marketing Strategy Template The SaaS Marketing Agency INTRODUCTION Why do you need a Marketing Strategy? Do you want more customers, leads or website traffic? Do you want to understand what marketing
More informationResearch and development case study. Human health research
Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published
More informationSETTING THE STAGE. Orientation to Customer Discovery. April 24, Webinar will begin at 1:00 pm ET
SETTING THE STAGE Orientation to Customer Discovery April 24, 2018 Webinar will begin at 1:00 pm ET PRESENTER Grant M. Warner, Ph.d. Director of Innovation, Graduate School Center for Advanced Manufacturing,
More informationThe In Vitro Diagnostic CRO
The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro
More informationFORMOR INTERNATIONAL
FORMOR INTERNATIONAL WE KNOW WHAT YOUR THINKING... SO, LET GET S REAL. FORMOR IS A Real Business Opportunity! This is NOT a SCAM or SCHEME WHAT IT IS NOT: - A PYRAMID OR PONZIE SCHEME - A GET RICH QUICK
More informationGet to market. You want to develop medical devices that are safe, effective, and compliant. We ll show you the most efficient path.
Get to market. You want to develop medical devices that are safe, effective, and compliant. We ll show you the most efficient path. Clinical Research Services We ve been the world s leading medical device
More informationLegal Notice: COPYRIGHT: Copyright 2013 Hitman Advertising, all rights reserved. LIMITS OF LIABILITY / DISCLAIMER OF WARRANTY:
Legal Notice: COPYRIGHT: Copyright 2013 Hitman Advertising, all rights reserved. LIMITS OF LIABILITY / DISCLAIMER OF WARRANTY: This report is NOT legal or accounting advice. You need to do your own due
More information